Literature DB >> 20097805

Streptomyces coelicolor A3(2) CYP102 protein, a novel fatty acid hydroxylase encoded as a heme domain without an N-terminal redox partner.

David C Lamb1, Li Lei, Bin Zhao, Hang Yuan, Colin J Jackson, Andrew G S Warrilow, Tove Skaug, Paul J Dyson, Eric S Dawson, Steven L Kelly, David L Hachey, Michael R Waterman.   

Abstract

The gene from Streptomyces coelicolor A3(2) encoding CYP102B1, a recently discovered CYP102 subfamily which exists solely as a single P450 heme domain, has been cloned, expressed in Escherichia coli, purified, characterized, and compared to its fusion protein family members. Purified reconstitution metabolism experiments with spinach ferredoxin, ferredoxin reductase, and NADPH revealed differences in the regio- and stereoselective metabolism of arachidonic acid compared to that of CYP102A1, exclusively producing 11,12-epoxyeicosa-5,8,14-trienoic acid in addition to the shared metabolites 18-hydroxy arachidonic acid and 14,15-epoxyeicosa-5,8,11-trienoic acid. Consequently, in order to elucidate the physiological function of CYP102B1, transposon mutagenesis was used to generate an S. coelicolor A3(2) strain lacking CYP102B1 activity and the phenotype was assessed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097805      PMCID: PMC2838009          DOI: 10.1128/AEM.03000-09

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  25 in total

1.  Fusarium oxysporum fatty-acid subterminal hydroxylase (CYP505) is a membrane-bound eukaryotic counterpart of Bacillus megaterium cytochrome P450BM3.

Authors:  T Kitazume; N Takaya; N Nakayama; H Shoun
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 2.  Biotransformations using prokaryotic P450 monooxygenases.

Authors:  Vlada Urlacher; Rolf D Schmid
Journal:  Curr Opin Biotechnol       Date:  2002-12       Impact factor: 9.740

3.  Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2).

Authors:  S D Bentley; K F Chater; A-M Cerdeño-Tárraga; G L Challis; N R Thomson; K D James; D E Harris; M A Quail; H Kieser; D Harper; A Bateman; S Brown; G Chandra; C W Chen; M Collins; A Cronin; A Fraser; A Goble; J Hidalgo; T Hornsby; S Howarth; C-H Huang; T Kieser; L Larke; L Murphy; K Oliver; S O'Neil; E Rabbinowitsch; M-A Rajandream; K Rutherford; S Rutter; K Seeger; D Saunders; S Sharp; R Squares; S Squares; K Taylor; T Warren; A Wietzorrek; J Woodward; B G Barrell; J Parkhill; D A Hopwood
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

4.  The cytochrome P450 complement (CYPome) of Streptomyces coelicolor A3(2).

Authors:  David C Lamb; Tove Skaug; Hong-Lin Song; Colin J Jackson; Larissa M Podust; Michael R Waterman; Douglas B Kell; Diane E Kelly; Steven L Kelly
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

5.  Biosynthesis of the sesquiterpene antibiotic albaflavenone in Streptomyces coelicolor A3(2).

Authors:  Bin Zhao; Xin Lin; Li Lei; David C Lamb; Steven L Kelly; Michael R Waterman; David E Cane
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

6.  Cytochrome p450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2).

Authors:  David C Lamb; Haruo Ikeda; David R Nelson; Jun Ishikawa; Tove Skaug; Colin Jackson; Satoshi Omura; Michael R Waterman; Steven L Kelly
Journal:  Biochem Biophys Res Commun       Date:  2003-08-01       Impact factor: 3.575

7.  Characterization of stable human aromatase expressed in E. coli.

Authors:  Norio Kagawa; Hiroshi Hori; Michael R Waterman; Shiro Yoshioka
Journal:  Steroids       Date:  2004-04       Impact factor: 2.668

8.  Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.

Authors:  Mattias C U Gustafsson; Olivier Roitel; Ker R Marshall; Michael A Noble; Stephen K Chapman; Antonio Pessegueiro; Armand J Fulco; Myles R Cheesman; Claes von Wachenfeldt; Andrew W Munro
Journal:  Biochemistry       Date:  2004-05-11       Impact factor: 3.162

9.  Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase.

Authors:  Anton Glieder; Edgardo T Farinas; Frances H Arnold
Journal:  Nat Biotechnol       Date:  2002-10-07       Impact factor: 54.908

10.  Systematic insertional mutagenesis of a streptomycete genome: a link between osmoadaptation and antibiotic production.

Authors:  Amy Bishop; Sue Fielding; Paul Dyson; Paul Herron
Journal:  Genome Res       Date:  2004-04-12       Impact factor: 9.043

View more
  5 in total

Review 1.  Unusual properties of the cytochrome P450 superfamily.

Authors:  David C Lamb; Michael R Waterman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

Review 2.  Cytochromes P450 for natural product biosynthesis in Streptomyces: sequence, structure, and function.

Authors:  Jeffrey D Rudolf; Chin-Yuan Chang; Ming Ma; Ben Shen
Journal:  Nat Prod Rep       Date:  2017-08-30       Impact factor: 13.423

3.  Heme protein and hydroxyarginase necessary for biosynthesis of D-cycloserine.

Authors:  Takanori Kumagai; Kisho Takagi; Yusuke Koyama; Yasuyuki Matoba; Kosuke Oda; Masafumi Noda; Masanori Sugiyama
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

4.  Identification of a cyclosporine-specific P450 hydroxylase gene through targeted cytochrome P450 complement (CYPome) disruption in Sebekia benihana.

Authors:  Mi-Jin Lee; Hyun-Bum Kim; Yeo Joon Yoon; Kyuboem Han; Eung-Soo Kim
Journal:  Appl Environ Microbiol       Date:  2013-01-25       Impact factor: 4.792

5.  Characterization of a Virally Encoded Flavodoxin That Can Drive Bacterial Cytochrome P450 Monooxygenase Activity.

Authors:  David C Lamb; Jared V Goldstone; Bin Zhao; Li Lei; Jonathan G L Mullins; Michael J Allen; Steven L Kelly; John J Stegeman
Journal:  Biomolecules       Date:  2022-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.